Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.

Robert ProvenzanoLynda SzczechRobert LeongKhalil G SaikaliMing ZhongTyson T LeeDustin J LittleMark T HouserLars FrisonJohn HoughtonThomas B Neff

Published in: Clinical journal of the American Society of Nephrology : CJASN (2022)

A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis, NCT01750190; Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis (ALPS), NCT01887600; Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis, NCT02174627.

Keyphrases

chronic kidney disease
end stage renal disease
peritoneal dialysis
ejection fraction
newly diagnosed
iron deficiency
clinical trial
open label
phase iii